학술논문

Brentuximab Vedotin Combined With Chemotherapy in Patients With Newly Diagnosed Early-Stage, Unfavorable-Risk Hodgkin Lymphoma.
Document Type
journal article
Source
Journal of Clinical Oncology; 7/0/2021, Vol. 39 Issue 20, p2257-2265, 9p
Subject
Language
ISSN
0732183X